Search

Your search keyword '"Agüera, Eduardo"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Agüera, Eduardo" Remove constraint Author: "Agüera, Eduardo" Database MEDLINE Remove constraint Database: MEDLINE
48 results on '"Agüera, Eduardo"'

Search Results

1. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.

2. Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.

Catalog

Books, media, physical & digital resources

3. Use of Cyrene™, as an alternative to dimethyl sulfoxide, as a diluent for Melatonin to determine its in vitro antimicrobial capacity.

4. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.

5. Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis.

6. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis.

7. Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019.

8. Follow-Up Findings in Multiple System Atrophy from [ 123 I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study.

9. Effect of the Combination of Different Therapies on Oxidative Stress in the Experimental Model of Multiple Sclerosis.

10. Diagnostic Effectiveness of [ 123 I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy.

11. Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.

12. Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.

13. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action.

14. The ultrastructure of muscle fibers and satellite cells in experimental autoimmune encephalomyelitis after treatment with transcranial magnetic stimulation.

15. SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.

16. Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.

17. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology.

18. Measuring productivity loss in early relapsing-remitting multiple sclerosis.

19. Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis.

20. Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation.

22. Genomic surveillance of enterovirus associated with aseptic meningitis cases in southern Spain, 2015-2018.

23. Transcranial Magnetic Stimulation Improves Muscle Involvement in Experimental Autoimmune Encephalomyelitis.

24. Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

25. Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial.

26. Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report.

27. The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.

28. Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models.

29. Denervated muscle extract promotes recovery of muscle atrophy through activation of satellite cells. An experimental study.

30. Implications of Vitamin D in Multiple Sclerosis and Other Neurodegenerative Processes: Bibliometric Analysis and Systematic Review.

31. Effects of transcranial magnetic stimulation on oxidative stress in experimental autoimmune encephalomyelitis.

32. Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis.

33. Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.

34. Muscular hypertrophy and atrophy in normal rats provoked by the administration of normal and denervated muscle extracts.

35. Skeletal muscle findings in experimental autoimmune encephalomyelitis.

36. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.

37. Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress.

38. Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.

39. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.

40. NGF and nitrosative stress in patients with Huntington's disease.

41. Peripheral oxidative stress in relapsing-remitting multiple sclerosis.

42. Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain.

43. Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels.

44. Important role of oxidative stress biomarkers in Huntington's disease.

45. Quantitative changes in the testicular structure in mice exposed to low doses of cadmium.

46. Myosin heavy chain fibre types and fibre sizes in nuliparous and primiparous ovariectomized Iberian sows: Interaction with two alternative rearing systems during the fattening period.

47. Intracranial portion of the trochlear nerve and dorsal oblique muscle composition in dog: a structural and ultrastructural study.

48. Quantitative modification of the testicular structure in pigs fed with anabolic doses of clenbuterol.